Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stockholm - Delayed Quote SEK

Spago Nanomedical AB (publ) (SPAGO.ST)

Compare
0.2170
-0.0010
(-0.46%)
At close: April 16 at 1:33:40 PM GMT+2
Currency in SEK All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,911
1,911
1,203
1,054
660
Cost of Revenue
14,269
14,269
24,486
16,658
17,436
Gross Profit
-12,358
-12,358
-23,283
-15,604
-16,776
Operating Expense
21,355
21,355
19,790
23,481
22,291
Operating Income
-33,713
-33,713
-43,073
-39,085
-39,067
Net Non Operating Interest Income Expense
1,204
1,204
850
268
120
Pretax Income
-32,509
-32,509
-42,223
-39,197
-39,071
Net Income Common Stockholders
-32,509
-32,509
-42,223
-39,197
-39,071
Diluted NI Available to Com Stockholders
-32,509
-32,509
-42,223
-39,197
-39,071
Basic EPS
-0.11
--
-0.43
-0.58
-0.95
Diluted EPS
-0.11
--
-0.43
-0.58
-0.95
Basic Average Shares
295,416.7090
--
97,978.0830
66,808.3700
41,262.3870
Diluted Average Shares
349,484.6210
--
104,954.5880
67,188.7670
41,851.3680
Total Operating Income as Reported
-33,713
-33,713
-43,073
-39,465
-39,192
Total Expenses
35,624
35,624
44,276
40,139
39,727
Net Income from Continuing & Discontinued Operation
-32,509
-32,509
-42,223
-39,197
-39,071
Normalized Income
-32,509
-32,509
-42,223
-39,197
-39,071
Interest Income
1,204
1,204
850
--
--
Net Interest Income
1,204
1,204
850
268
120
EBIT
-33,713
-33,713
-43,073
-39,085
-39,067
EBITDA
-33,401
-33,401
-42,792
-38,729
-38,691
Reconciled Cost of Revenue
14,269
14,269
24,486
16,658
17,436
Reconciled Depreciation
312
312
281
356
376
Net Income from Continuing Operation Net Minority Interest
-32,509
-32,509
-42,223
-39,197
-39,071
Normalized EBITDA
-33,401
-33,401
-42,792
-38,729
-38,691
12/31/2021 - 1/16/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers